Shareholder Michael D. Harris, Esq. led a team of attorneys from Nason Yeager in representing Bothell, WA based Cocrystal Pharma, Inc. [OTCBB: COCP] in its merger with Tucker, GA based RFS Pharma, LLC. Structured as a merger of equals, the transaction had a fully diluted market value of … [Read more...]
Nason Yeager Assists Clients with Closing Two Public Company Mergers
Shareholder Michael D. Harris, Esq., who heads the firm's SEC and Mergers and Acquisitions practice, led teams of Nason Yeager lawyers in closing two public company mergers in March. In the first merger, Nason Yeager client, Vaporin, Inc., a publicly-traded OTC Markets issuer then based in … [Read more...]
Nason Yeager Represents Biozone Pharmaceuticals, Inc. in Two Significant Transactions
Nason, Yeager, Gerson, White & Lioce, P.A. represented Pittsburg, California based Biozone Pharmaceuticals, Inc. [publicly-traded California based company] in the sale of all of its operating assets and in the acquisition of a Seattle, Washington area biotechnology company. Both transactions … [Read more...]
Nathan “Nat” Nason Successfully Pilots Probate Settlement Negotiations
Nason Yeager Shareholder, Nathan E. "Nat" Nason, successfully settled a dispute involving the probate of an estate worth over $10 million dollars. Mr. Nason represented an intestate heir in the dispute. Midway through the trial, which pitted a large group of intestate heirs who stood to inherit if … [Read more...]
- « Previous Page
- 1
- …
- 7
- 8
- 9